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Sex, health and morality…PrEP and the HIV challenge 
The announcement this week that the National AIDS Trust had won its high court 
challenge that funding for Pre-exposure Prophylaxis (PrEP) could be provided by 
NHS England made the headlines. The initial media furore highlighted HIV/AIDS 
activists' beliefs that costs for prevention as well as treatment of HIV lie within the 
remit of the national organisation. This counteracted the insistence of NHS England 
that funding the use of PrEP in a preventive mode meant that the costs should be 
met by Local Authorities as part of their existing responsibilities for public health. 
Inevitably, much was made in the TV news and newspaper articles that followed 
about the costs of the treatment - £400 per person per month- as well as the focus of 
its use in the preceding research trial, by Gay men.  
Reading and reflecting on the news that day I was acutely aware that within the 
silences existing between the headlines and implied within the issues raised, we 
were witnessing two things: 
a) A reminder of the dark past and 'moral' rhetoric about HIV/AIDS 
b) the evidencing of a milestone in HIV/AIDs 'care'  
30 years ago I qualified as a nurse from Sheffield city Polytechnic ( now Sheffield 
Hallam University). 1986 signalled not only this, but the start of what many may 
remember as the 'AIDS pandemic' in the UK. Worldwide at that time, young, 
otherwise healthy young men in particular were dying. The cause of their suffering 
was unknown and it would be years before we isolated the HIV virus as the 
precursor to this terrible disease and the suffering it bought - in the interim, many 
thousands would die and furthermore, thousands more would suffer the social, 
political and moral backlash arising from a global 'fear' of this unknown killer.  
My early years as a newly qualified nurse , working in sexual health were shaped by 
the affects and effects of AIDS on society. working as a nurse/outreach worker  at 
that time I witnessed individuals and communities disrespected, abused and vilified 
for simply belonging to what where termed 'risk groups' Gay men suffered the brunt 
of this public reaction along with African communities, drug users and prostitutes - 
These groups were identified as bringing on the disease themselves due to their 
'lifestyle choices' and were therefore blamed for the condition - the immorality labels 
were not extended to two of the other groups identified as 'high' risk - thus breast 
feeding mothers and haemophiliacs were conversely labelled as 'innocent victims' of 
AIS, with pity replacing the vilification visited upon the other groups.  The successful 
use of PrEP to prevent transmission of HIV is a milestone in our battle to manage 
and minimise the effects of this terrible disease. It signals the success of science and 
health focussed research in advancing our understanding of HIV/AIDs such that it is 
now a chronic condition rather than a life threatening one. people living with HIV are 
no longer dying in the UK within weeks of diagnosis as they were in the 1980s but 
living well into adulthood, able to fulfil their own life plans and society benefits as a 
result.  
Why is this important now? and what was it about the news items that followed the 
announcement this week that makes me raise this issue again? Well 30 years on I 
listened again to news items and commentaries which raised the question of whether 
'public money' should be spent on a drug to prevent a condition which is easily 
managed through simple condom use. This in itself appears an innocent and valid 
question, but within the discussions this assertion was often followed by concern 
about the 'risk' of seeming to encourage hedonistic lifestyles, promiscuity and lack of 
responsibility among Gay men should the drug be provided. what struck me was the 
emphasised link made between a prescribing a drug to prevent HIV transmission 
and inevitably enabling gay me to take less responsibility for their health. Hidden 
behind thee statements lie assertions I had witnessed 30 years previously - that 
sexual health and prevention of suffering from sexually transmitted diseases was a 
questionable use of public money in cases where individuals should excise' control'. 
what is interesting once again, is that the same questions are no longer directed to 
new innovations for contraceptive drugs…indeed the pursuit of the 'male pill' and 
less intrusive ways of managing fertility continue. This raises for me the unspoken 
question of whether £400 per person would be questioned less if the trial which 
evidenced the effectiveness of PrEP as a preventative drug focused on heterosexual 
sexual relationships rather than Gay men. It seems that while the treatment and 
management of HIV/AIDS has moved on, the views of many of the public have not.  
The aim of advances in health and medicine is to alleviate suffering and improve our 
ability to lead healthy and happy lives. if we have the means and opportunity to do so 
through advances in medicine a, technology or understanding it is our duty to do so. 
Questions about who should pay and whether the spend in warranted in relation to 
cost- benefit are always valid. However I also believe that we must not lose sight of 
how easy it is to return to the marginalisation and 'immorality' discourse which 
hampered our efforts in the past. we have had many successes in HIV work and 
thankfully sexual health as a whole has been rightfully recognised as an essential 
part of our rights as human beings. so while we rightfully ensure that scarce 
resources are used appropriately to the benefit of the whole population - let us not 
forget the Mission of the NHS at its inception which is still written within the purpose 
of the Five Year Forward view : " high quality care for all, free at the point of need" 
